Author Search Results

Moussa B. H. Youdim

Moussa B. H. Youdim is an Israeli neuroscientist specializing in neurochemistry and neuropharmacology. He is the discoverer of both monoamine oxidase (MAO) B inhibitors l-deprenyl (Selegiline) and rasagiline (Azilect) as anti-Parkinson drugs which possess neuroprotective activities. He is currently professor emeritus at Technion - Faculty of Medicine and President of Youdim Pharmaceuticals. Provided by Wikipedia

1

Correction for the article “Why Do We Need Multifunctional Neuroprotective and Neurorestorative Drugs for Parkinson’s and Alzheimer’s Disorders?” by Moussa B. H. Youdim

by Moussa B.H. Youdim
Published 2015-10-01

Get full text

Article
2

Why Do We Need Multifunctional Neuroprotective and Neurorestorative Drugs for Parkinson’s and Alzheimer’s Disorders?

by Moussa B.H. Youdim
Published 2010-10-01

Get full text

Article
3

Activation of tyrosine kinase receptor signaling pathway by rasagiline facilitates neurorescue and restoration of nigrostriatal dopamine neurons in post-MPTP-induced parkinsonism

by Yotam Sagi, Silvia Mandel, Tamar Amit, Moussa B.H. Youdim
Published 2007-01-01

Get full text

Article
4

Neuroprotection and Neuroregeneration in Alzheimer's Disease

by Kiminobu Sugaya, Moussa B. H. Youdim, Agneta Nordberg, K. S. Jagannatha Rao
Published 2012-01-01

Get full text

Article
5

Monoamine oxidase A upregulated by chronic intermittent hypoxia activates indoleamine 2,3-dioxygenase and neurodegeneration.

by Chun-Sing Lam, Jing-Jie Li, George Lim Tipoe, Moussa B H Youdim, Man-Lung Fung
Published 2017-01-01

Get full text

Article
6

A Novel Antioxidant Multitarget Iron Chelator M30 Protects Hepatocytes against Ethanol-Induced Injury

by Jia Xiao, Yi Lv, Bin Lin, George L. Tipoe, Moussa B. H. Youdim, Feiyue Xing, Yingxia Liu
Published 2015-01-01

Get full text

Article
7

M30 Antagonizes Indoleamine 2,3-Dioxygenase Activation and Neurodegeneration Induced by Corticosterone in the Hippocampus.

by Chun-Sing Lam, George Lim Tipoe, Johnny Kong-Ching Wong, Moussa B H Youdim, Man-Lung Fung
Published 2016-01-01

Get full text

Article
8

Correction: I1 Imidazoline Receptor: Novel Potential Cytoprotective Target of TVP1022, the S-Enantiomer of Rasagiline

by Yaron D. Barac, Orit Bar-Am, Esti Liani, Tamar Amit, Luba Frolov, Elena Ovcharenko, Itzchak Angel, Moussa B. H. Youdim, Ofer Binah
Published 2013-01-01

Get full text

Article
9

I1 imidazoline receptor: novel potential cytoprotective target of TVP1022, the S-enantiomer of rasagiline.

by Yaron D Barac, Orit Bar-Am, Esti Liani, Tamar Amit, Luba Frolov, Elena Ovcharenko, Itzchak Angel, Moussa B H Youdim, Ofer Binah
Published 2012-01-01

Get full text

Article
10

Correction: I Imidazoline Receptor: Novel Potential Cytoprotective Target of TVP1022, the S-Enantiomer of Rasagiline.

by Yaron D. Barac, Orit Bar-Am, Esti Liani, Tamar Amit, Luba Frolov, Elena Ovcharenko, Itzchak Angel, Moussa B. H. Youdim, Ofer Binah
Published 2013-01-01

Get full text

Article
11

Multi-target directed donepezil-like ligands for Alzheimer's disease

by Mercedes eUnzeta, Gerard eEsteban, Irene eBolea, Wieslawa Agnieszka Fogel, RONA R. RAMSAY, Moussa B.H. Youdim, Keith F Tipton, Jose eMarco-Contelles
Published 2016-05-01

Get full text

Article